A B S T R A C T The present study determined the effects of 1,25-dihydroxycholecalciferol on serum immunoreactive parathyroid hormone and on parathyroid hormone secretion in vitro. Rats injected i.p. with 1,25-dihydroxycholecalciferol, 130 pmol (2 U)/140 g body wt, which is probably a physiologic dose, had a significant 43% decrease in serum immunoreactive parathyroid hormone at 4 h. In addition, this dose of 1,25-dihydroxycholecalciferol inhibited the serum immunoreactive parathyroid hormone response to hypocalcemia induced by phosphate injection. Because the increment in serum immunoreactive parathyroid hormone was less but the decrement in serum calcium more in phosphate plus 1,25-dihydroxycholecalciferol-treated than in phosphate plus vehicle-treated rats, the impaired serum immunoreactive parathyroid hormone response to 1,25-dihydroxycholecalciferol could not be attributed to the change in serum calcium. In studies of parathyroid hormone secretion from bovine parathyroid tissue in vitro, the concentration of 1,25-dihydroxycholecalciferol used for most experiments was 1 nM, which is in the range found in rat serum. 1,25-Dihydroxycholecalciferol at 1 or 100 nM significantly inhibited parathyroid hormone secretion when medium calcium concentration was normal (1.5 mM), high (3.0 mM), and low (1.0 mM).
INTRODUCTION
and serum iPTH.
Total volume infused per rat in both groups was 0.4 ml.
The animals were under light ether anesthesia during the 8-min experiment.
Rat serum iPTH assay. The method used to perform this assay was similar to that described by Arnaud, Tsao, and Littledike for human serum iPTH (15) . Highly purified bovine PTH, generously supplied by Dr. J. Hamilton, Kansas City, Mo., was used to prepare the iodinated tracer and as the standard for the assay. Iodination of the hormone with 'I of high specific activity (Industrial Nuclear Co., Inc., St. Louis, Mo.) was accomplished by the Berson and Yalow modification of the method of Greenwood and associates (16) . The iodinated PTH was purified with QUSO G-32 (Philadelphia Quartz Co., Chester, Pa.) as described by Yalow and Berson (17) . The antiserum used, generously supplied by Dr. C. Arnaud, Mayo Clinic, Rochester, Minn., was chicken-12 anti-bovine antiserum, which predominantly detects the region of bovine PTH that is carboxyl-terminal to amino acid residue 34 (Fig. 2) ; increased 118%o when serum calcium was decreased 8% (Fig. 4) ; increased 301% when serum calcium was decreased 34% (Table I) ; and increased more than 10-fold in chronically hypocalcemic rats (serum calcium 5.1 mg/100 ml at time of assay; see Fig. 1 ).
In vitro studies of the iPTH secretion rate. Because the technique used to measure the rate of bovine PTH secretion in vitro and the application of this technique to study PTH secretion have been described previously (18) (19) (20) 1-34 was significantly greater than zero, and the slope of % B/F as a function of molar concentration of bovine PTH 1-84 was significantly greater than the slope with bovine PTH 1-34. Therefore, because both standards exhibited competition with tracer and because bovine PTH 1-84 exhibited greater competition than bovine PTH 1-34, this antiserum detects both amino and carboxyl terminals of bovine PTH. However, based on the data from this experiment, the sensitivity of this antiserum was greater for the carboxyl than for the amino terminal of bovine PTH. The final results were corrected for blank values obtained with unused medium in a manner similar to that described by Arnaud and associates for serum (15) . In the bovine PTH assay, the intra-and interassay coefficients of variation were ±8 and ± 13%, respectively. Media from individual experiments were analyzed in the same assay. Analysis of variance or Student's t test was used to determine statistical 0.5 significance (21 In this in vitro assay system, PTH secretion from bovine parathyroid tissue into medium changed in the appropriate direction in response to changes in medium calcium concentration. Accordingly, PTH secretion increased when the medium contained a low calcium concentration and decreased when the medium contained a high calcium concentration (18) (Figs. 5 and 6) . RESULTS
Effects of 1,25-(OH) .D3 on serum iPTH in rats.
In normal rats 4 h after i. (Fig. 4) .
In the vehicle-treated group, compared with the control group (which received vehicle plus saline but not phosphate), phosphate injection caused a significant decrease in serum calcium at 4 h (P < 0.02), but the decrement at 8 h was not statistically significant. In the 1,25-(OH)2D3-treated group, phosphate injection caused a marked and significant decrease in serum calcium at 4 h (P <0.001), and the decrement at 8 h was still significant (P < 0.01). The decrement in serum calcium was greater in the 1,25-(OH)2D3 than in the vehicletreated group at 4 h (P < 0.005) and at 8 h, but at the latter time interval the difference was not statistically ' (Fig. 4) .
In animals injected with different doses of phosphate, there was an inverse relationship between serum calcium and iPTH (Table I) . Thus, because serum calcium was lower in the group treated with phosphate plus 1,25-(OH) 2D3 than in the group treated with phosphate plus vehicle, the decreased serum iPTH response as a result of 1,25-(OH)2D3 treatment is particularly noteworthy (Fig. 4) .
Effect In bovine parathyroid tissue incubated in a low-calcium medium (1.0 mM), the PTH secretion rate, as compared with basal PTH secretion rate (i.e., when medium calcium was 1.5 mM), was significantly increased at 1-4 h (Fig. 5) . In bovine parathyroid tissue incubated in a high-calcium medium (3.0 mM), the PTH secretion rate, compared with the basal secretion rate, was significantly decreased at 1-4 h (Fig. 6) . Though a control group with a medium calcium of 1.5 mM was not included in the present study, previous work with this in vitro system indicates that throughout the incubation period a low-calcium medium (0.75 mM) causes an increase in the PTH secretion rate and that a high-calcium medium (3.0 mM) depresses PTH secretion (18). 1,25-(OH)2D3 at 1 nM significantly decreased the effect of a low-calcium medium to increase PTH secretion rate; this effect was evident (statistically significant) at 2 h and persisted or perhaps was progressive thereafter (Fig. 5) . Additionally, (Fig. 6 ).
In recent work, Chertow and co-workers showed that vitamin A stimulates the PTH secretion rate in vitro (19) . This effect was confirmed in the present study where vitamin A at 0.1 ,oM caused a marked stimulation of the PTH secretion rate (Fig. 7) . The maximum increment in the PTH secretion rate was seen at 1 h, and thereafter the effect decreased with time (Fig. 7) . 1,25-(OH)2D8 at 1 nM inhibited the effect of vitamin A to increase the PTH secretion rate; the inhibitory effect of 1,25-(OH)2D3 was evident (statistically significant) at 1 h and persisted throughout the remainder of the experiment (Fig. 7) . When the PTH secretion rates were plotted as a percentage of control, the curves for vitamin A and vitamin A plus 1,25-(OH)2D3 were quite similar in shape (Fig. 7 ).
These curves would be consistent with either an effect of 1,25-(OH) 2D8 to decrease the basal level of secretion or to inhibit specifically the action of vitamin A on PTH secretion. Effect of hydrocortisone on the rate of PTH secretion in vitro. In order to evaluate the specificity of the inhibitory effect of 1,25-(OH)2Ds on PTH secretion, the effect of another steroid, hydrocortisone, on (18, 19) . Additionally, the validity of these assays is supported by the internal consistency of our in vivo and in vitro data.
The molecular species (i.e., native PTH, pro-PTH, or PTH fragments) and fate of secreted PTH are also pertinent to the interpretation of the effect of 1,25-(OH)2Da in terms of PTH secretion. With respect to in vitro work, Sherwood, Rodman, and Lundberg obtained evidence from bovine parathyroid tissue that glandular or native PTH (mol wt 9,500) was a precursor which was converted to a smaller mol wt (mol wt 7,000) and then apparently secreted into medium (22) . Fischer, Oldham, Sizemore, and Arnaud (23) and Arnaud and co-workers (24) , working with porcine and human parathyroid tissue, respectively, also found evidence that the predominant secreted species in vitro was smaller than native hormone but biologically active. In contrast, other laboratories have obtained evidence that bovine pro-PTH is a larger mol wt species than native PTH, that pro-PTH is not secreted in vitro, and that the predominant species secreted in vitro is native hormone (25) (26) (27) . Our in vitro results tend to agree with the conclusion that the hormone secreted is native hormone, in that secreted PTH was immunologically indistinguishable from native PTH (18) . In any case, the majority if not all of the above studies are consistent with the concept that the predominant species secreted in vitro is not pro-PTH and is biologically active. Regarding the fate of secreted PTH, some (27) but not all workers (22) found that when radioactive PTH was added to the medium of parathyroid tissue slices there was degradation of the labeled hormone. Because our antiserum has greater sensitivity for the carboxyl than for the amino terminal of PTH, it is possible that in vitro degradation of native PTH could spuriously affect the quantitation, based on medium iPTH analyses, of the amount of hormone secreted. This seems unlikely, however, because the amount of degradation of labeled native hormone in vitro in 1 h is negligible (27) and because our medium was changed hourly or more frequently. Thus, if, as seems likely, the major species secreted was native PTH and since PTH degradation in medium under our conditions was negligible, our in vitro results indicate that 1,25-(OH)2D8 decreases secretion of native PTH.
Our in vivo serum iPTH results, while not a direct measure of PTH secretion, may reflect changes in secretion. Although there is indirect evidence in humans that PTH fragments can be secreted (28) , other studies suggest that in both humans and cows, secreted hormone is largely native PTH (29, 30) . However, the domnant form of circulating PTH in humans and cows appears to be small mol wt fragments (30, 31) . Nevertheless, changes in serum iPTH tend to reflect changes in the secretion of native hormone (12, 15, 31) . Although rat parathyroid tissue has been shown to synthesize pro-PTH (32), neither the secreted nor circulating species of PTH in rats has been studied. Interpreted in the light of the above data and our in vitro data, our finding that 1,25-(OH)2D3 decreases serum iPTH in rats strongly suggests but does not establish that 1,25-(OH)2D3 decreases PTH secretion in vivo.
Concerning the issue of 1,25-(OH)2D3 dosage, the concentration of 1,25-(OH)2Ds in bovine serum is unknown; however, in rats fed vitamin D3, the basal level of serum 1,25-(OH)2D8 was 17 ng/100 ml or 0.41 nM and the level in response to a calcium-deficient diet was about 100 ng/100 ml or 2.5 nM (32a). Thus, the concentration of 1,25-(OH)2D8used in our in vitro work, 1 nM, is within the range of that found in rat serum. However, because 1,25-(OH) 2D3, like cholecalciferol and 25-hydroxycholecalciferol (33) , may be largely bound in serum to carrier proteins and because our incubation medium contained only 10% calf serum, it is possible that the level of free, and presumably active, 1,25-(OH)2D3 was greater in our incubation medium than in serum.
In any case, the dose we used is similar to that used by Raisz, Trummel, Holick, and DeLuca, who found by means of their in vitro resorbing system that a resorptive response to 1,25-(OH)2D8 was detectable at about 0.1 nM and that there was a log dose response between about 0.1 and 10 nM (34). 1,25-(OH)2Ds at 10 nM also stimulates calcium-45 uptake by intestine in vitro (35) . Thus, apart from the uncertainty of the issue of free 1,25-(OH)2D3 concentration, it would seem that the concentration of 1,25-(OHi)2D3 we used in our in vitro work is probably in the physiological range.
The physiologic dose of 1,25-(OH) 2D3 in vivo has not been established. In this study we used 130 pmol (2 U) of 1,25-(OH)2Ds, a dose that did not increase serum calcium. Other workers have used between 1 and 10 U of 1,25-(OH)2D3 for in vivo work with rats (36) (37) (38) (Table  III) .
Although the only vitamin D metabolite evaluated in this work was 1,25-(OH)2D8, recently Henry and Norman showed in vitamin D-deficient chicks that the concentration of radioactive 1,25-(OH) 2Ds, after injection of radioactive 1,25-(OH)2D3 or radioactive 25-OHDs, was higher in the parathyroid glands than in blood (40) . However, no evidence was found that either 25-OHD3 or 24,25-(OH)2D3 was concentrated by parathyroid glands (40) . This raises the possibility that 1,25-(OH)2D3 is the predominant vitamin D metabolite that acts on the parathyroid glands. Moreover this observation strengthens the conclusion that 1,25-(OH)2Ds plays a direct role in PTH secretion.
Our in vivo studies, in addition to being consistent with our in vitro work, disclosed an unexpected effect of 1,25-(OH) Ds on serum calcium. The degree of hypocalcemia in the rats given phosphate plus 1,25-(OH) 2D3 was greater than that in rats given phosphate alone (Fig. 4) . Of the various possible explanations for this change, the simplest one is that the greater degree of hypocalcemia was due to inhibition of PTH secretion by 1,25-(OH)2Ds. If so, a dose of 1,25-(OH) 2D3 that decreases serum iPTH does not appear to replace the effect of PTH to maintain serum calcium. If this explanation were correct, one would expect to find hypocalcemia in rats given sufficient 1,25-(OH) 2D3 to decrease serum iPTH; however, in the present study no decrease in serum calcium was found when serum iPTH was significantly depressed, at least when evaluated at the one time interval of 4 h (Fig. 3) . Further work will be required to resolve the interrelationship between 1,25-(OH) 2D3 and PTH on calcium metabolism.
The mechanism of PTH secretion differs from that of many hormones in that low external (i.e., medium or ECF) calcium stimulates rather than inhibits PTH secretion (18, 41) . The mechanism of PTH secretion is similar to that of many hormones in that it is probably mediated by cyclic AMP (18, 42) . (43) . With respect to the latter, it is of interest that an increase in cytoplasmic calcium can in some in vitro systems inhibit adenyl cyclase activity (41, 44) and in others inhibit cyclic AMP-mediated changes in enzyme activity (45 
